Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry [0.03%]
韩国肝细胞癌流行现状分析：基于2015年全国癌症登记数据
Jun Sik Yoon,Han Ah Lee,Hwi Young Kim et al.
Jun Sik Yoon et al.
Background/aims: Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cancer-related death in Korea. This study evaluated the characteristics of Korean patients newly diagnosed wi...
External Beam Radiotherapy for Hepatocellular Carcinoma: a Review of the Current Guidelines in the East and the West [0.03%]
肝细胞癌外照射治疗的东西方现状及展望——系统回顾系列文章之六
Sang Min Yoon
Sang Min Yoon
The incidence of hepatocellular carcinoma (HCC) is geographically heterogeneous depending on the underlying liver disease. Moreover, the decisions and recommendations about standard treatments differ between countries, especially between th...
The development of hepatocellular carcinoma during long-term treatment for recurrent non-small cell lung cancer: a case report [0.03%]
长期治疗复发性非小细胞肺癌期间肝细胞癌的发生发展：病例报告
Seong Kyun Na,Seong Hee Kang
Seong Kyun Na
Multiple primary malignancies (MPMs) are defined as the presence of two or more malignancies in different organs, without a subordinate relationship. Although rarely reported, hepatocellular carcinoma (HCC) occasionally presents with simult...
Adult hepatoblastoma: making the challenging distinction from hepatocellular carcinoma [0.03%]
成人肝母细胞瘤：与肝细胞癌鉴别的挑战
Allison Kaye L Pagarigan,Paulo Giovanni L Mendoza
Allison Kaye L Pagarigan
Hepatoblastoma is an exceptionally rare malignancy in adults with just over 70 non-pediatric cases reported in literature. Recounted is a case of a 49-year-old female who presented with acute right upper quadrant abdominal pain, elevated se...
Darine Daher,Karim Seif El Dahan,Amit G Singal
Darine Daher
Non-alcoholic fatty liver disease (NAFLD), one of the most common causes of liver disease, is an increasingly common cause of hepatocellular carcinoma (HCC). Several demographic, clinical, and genetic factors contribute to HCC risk in NAFLD...
How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion [0.03%]
如何优化大血管侵犯的晚期肝细胞癌治疗策略？
Beom Kyung Kim
Beom Kyung Kim
Shin Hye Hwang,Hyungjin Rhee
Shin Hye Hwang
The cross-sectional imaging findings play a crucial role in the diagnosis of hepatocellular carcinoma (HCC). Recent studies have shown that imaging findings of HCC are not only relevant for the diagnosis of HCC, but also for identifying gen...
Parenchymal-sparing hepatectomy for multiple bilobar colorectal liver metastases in a Jehovah's witness: a case report [0.03%]
一名耶和华见证者肝多发病灶患者行残肝保留型肝脏切除术的病例报告
Shehan Ratnayake,Duminda Subasinghe,Vihara Dassanayake et al.
Shehan Ratnayake et al.
Parenchymal-sparing hepatectomy (PSH), though technically challenging, is emerging as a choice of treatment for colorectal liver metastases (CRLM). PSH in Jehovah's witness (JW) patients, for whom transfusion is not an option, involves comp...
Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study [0.03%]
阿霉素缓释微球经导管动脉化疗栓塞治疗门静脉侵犯不可切除的肝细胞癌：一项前瞻性研究
Su Jong Yu,Yun Bin Lee,Eun Ju Cho et al.
Su Jong Yu et al.
Background/aim: To evaluate the applicability of transarterial chemoembolization (TACE) treatment with doxorubicin drug-eluting beads (DEBs) in advanced hepatocellular carcinoma (HCC) patients with portal vein invasion (P...
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment [0.03%]
射后阿特朱单抗联合贝伐珠单抗治疗后继发肝癌腹膜种植一例及其外科手术救治经验
Yuri Cho,Bo Hyun Kim,Tae Hyun Kim et al.
Yuri Cho et al.
Peritoneal seeding of hepatocellular carcinoma (HCC) is incurable and has poor prognosis. A 68-year-old man underwent surgical resection for a 3.5 cm single nodular HCC at the tip of segment 3 and transarterial chemoembolization for a 1.5 c...